The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Review on the Efficacy and Safety of Mahuang and Ephedrine in the Treatment of Obesity -Focused on RCT-

비만 치료에서 마황 및 에페드린의 유효성, 안전성에 대한 고찰 - RCT 연구를 중심으로 -

  • Received : 2017.09.05
  • Accepted : 2017.09.18
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The objective of this study was to summarize randomized clinical trials (RCTs) that have assessed efficacy and safety of mahuang and ephedrine on treatment of obesity and to propose better process of study. Methods: NLM Medline (pubmed), the Cochrane library, Scopus, Science Direct, RISS, KISS were systemically searched for clinical trials investigating the efficacy, safety of mahuang and ephedrine on treatment of obesity from 2000 to 2017. Results: 16 RCTs met all the inclusion criteria. In most reports, mahuang and ephedrine significantly reduced body weight, body fat mass. There were no serious adverse events associated with mahuang and ephedrine in all studies. Conclusions: In appropriate dose of mahuang and ephedrine for healthy adult was safe, and weight loss effect of mahuang and ephedrine was better than control group. Improved clinical practice guidelines should be developed for safe use of mahuang and ephedrine.

Keywords

References

  1. World Health Organization. Reducing Risks-Promoting healthy life. World Health Report 2002, Geneva, WHO 2002.
  2. Ministry of Health and Welfare. Korea Centers for Disease Control and Prevention. Korea Health Statistics 2014:Korea National Health and Nutrition Examination Survey (KNHANES VI-2).
  3. Kopelman P. Health risks associated with overweight and obesity. Obesity Reviews. 2007;8(1):13-17. https://doi.org/10.1111/j.1467-789X.2007.00311.x
  4. Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635-643. https://doi.org/10.1038/35007508
  5. Lee KW. Correct Obesity Drug Therapy. Korean Journal of International Medicine. 2009;77(4):971-976.
  6. Lee TH. Treatment of Obesity. Korean Journal of Medicine. 2001;61(3):227-233.
  7. Song YK, Lim HH. Clinical Application of Ma Huang in the Obesity Treatment. Journal of Society of Korean Medicine for Obesity Research. 2007:7(1):1-7.
  8. Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000-Mainly about Ephedra herba. Journal of Society of Korean Medicine for Obesity Research. 2007;7(1):39-54.
  9. Jeong JW, Cho SW. Trend research of the human body-Oriented obesity studies on Korean medicine. Journal of Korean Medicine Rehabilitation. 2016;26(1):49-61. https://doi.org/10.18325/jkmr.2016.26.1.49
  10. Lim SY, Park SW, Joo JH, Kim SR, Kim DJ, Choi WS. The effects of Taeeumjowui-tang (Taiyintiaowei-tang) on obesity in sasang constitution. The Journal of East-West Medicine. 2012;37(4):109-116.
  11. Professors of formula study of Korean Medicine School. Clinical Traditional Herbalogy. Seoul; Yeong-lim Press. 2016:236
  12. Andraws R, Chawla P, Brown DL. Cardiovascular effects of ephedra alkaloids: a comprehensive review. Progress in Cardiovascular Diseases. 2005;47(4): 217-25. https://doi.org/10.1016/j.pcad.2004.07.006
  13. Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol Sci. 2000;56(2):424-30. https://doi.org/10.1093/toxsci/56.2.424
  14. Jang IS, Hwang EH. The Need for Clinical Practice Guidelines in Usage of Mahuang in Weight Loss. Journal of Society of Korean Medicine for Obesity Research. 2007:(1):23-29.
  15. Department of Health and Human Services, Agency for Healthcare Research and Quality, Shekelle P, Hardy ML, Morton SC, Maglione M, Suttorp M, et al. Ephedra and ephedrine for weight loss and athletic performance enhancement: Clinical efficacy and side effects. Available at: URL:http://www.fda.gov/OHRMS/DOCKETS/98fr/95n-0304-bkg0003-ref-07-01-index.htm. Accessed June, 2007.
  16. Kim HJ, Han CH, Lee EJ, Song YK, Shin BC, Kim YK. A clinical practice guideline for Ma-huang(Ephedra sinica) prescription in obesity. Journal of Society of Korean Medicine for Obesity Research. 2007;7(2):27-37.
  17. Liu AG, Smith SR, Fujioka K, Greenway FL. The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. Obesity. 2013;21(10): 1991-1996. https://doi.org/10.1002/oby.20416
  18. Kim HJ, Park JM, Kim JA, Ko BP. Effect of Herbal Ephedra sinica and Evodia rutaecarpa on Body Composition and Resting Metabolic Rate: A Randomized, Double-blind Clinical Trial in Korean Premenopausal Women. Journal of Acupuncture and Meridian Studies. 2008;1(2):128-138. https://doi.org/10.1016/S2005-2901(09)60033-9
  19. Hackman RM, Havel PJ, Schwartz JH, Rutledge JC, Watnik MR, Nocite EM, et al. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: A randomized controlled trial. International Journal of Obesity. 2006;30(10):1545-1556. https://doi.org/10.1038/sj.ijo.0803283
  20. Vukovich MD, Schoorman R, Heilman C, Jacob P, Benowitz NL. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clinical and Experimental Pharmacology and Physiology. 2005;32(1-2):47-53. https://doi.org/10.1111/j.1440-1681.2005.04152.x
  21. Haller CA, Jacob P, Benowitz NL. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Clinical pharmacology and therapeutics. 2005;77(6):560-71. https://doi.org/10.1016/j.clpt.2005.01.023
  22. McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. Journal of American Medical Association. 2004;291(2):216-21. https://doi.org/10.1001/jama.291.2.216
  23. Hioki C, Yoshimoto K, Yoshida T. Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clinical and experimental pharmacology & physiology. 2004;31(9):614-9. https://doi.org/10.1111/j.1440-1681.2004.04056.x
  24. Haller CA, Jacob P, Benowitz NL. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clinical pharmacology and therapeutics. 2004;75(4):259-73. https://doi.org/10.1016/j.clpt.2003.11.375
  25. Greenway FL, Jonge L, Blanchard D, Frisard M, Smith SR. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obesity Research. 2004;12(7):1152-1157. https://doi.org/10.1038/oby.2004.144
  26. Coffey CS, Steiner D, Baker BA, Allison DB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. International Journal of Obesity. 2004;28(11):1411-1419. https://doi.org/10.1038/sj.ijo.0802784
  27. Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2002:26;363-1366.
  28. Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2002;26(5), 593-604. https://doi.org/10.1038/sj.ijo.0802023
  29. Zaragoza RM, Lonngi G, Ortiz RA, Huerta DR. Comparison of two formulations of d-norpseudoephedrine and placebo in obese patients treated during six months. Medicina Interna de Mexico. 2001:17(6);260-71.
  30. Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2001:25(3);316-24. https://doi.org/10.1038/sj.ijo.0801539
  31. Molnar D, Torok K, Erhardt E, Jeges S. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2000:24(12);1573-8. https://doi.org/10.1038/sj.ijo.0801433
  32. Kalman DS, Colker CM, Shi Q, Swain MA. Effects of a weight-loss aid in healthy overweight adults: Double-blind, placebo-controlled clinical trial. Current Therapeutic Research - Clinical and Experimental. 2000:61(4);199-205. https://doi.org/10.1016/S0011-393X(00)89034-7
  33. Jang IS, Yang CS, Hwang EH. The need for clinical practice guidelines in usage of Mahuang in weight loss. Journal of Society of Korean Medicine for Obesity Research. 2007:7(1):23-29.

Cited by

  1. 가미 태음조위탕과 저열량 식이를 병행한 체중 감량 프로그램에서 발생한 이상 반응 분석 vol.18, pp.1, 2017, https://doi.org/10.15429/jkomor.2018.18.1.1
  2. 마황이 포함된 한방비만 처방과 Lorcaserin 병용 투여 후 호전된 비만 환자 치험 2예 vol.19, pp.1, 2017, https://doi.org/10.15429/jkomor.2019.19.1.79
  3. 소청룡탕 복용 후 혈당이 상승한 당뇨병 환자 증례보고 vol.40, pp.5, 2017, https://doi.org/10.22246/jikm.2019.40.5.929
  4. 한의 체중 조절 프로그램에 참여한 과체중, 비만 환자에서의 머신러닝 기법을 적용한 체중 감량 예측 연구 vol.41, pp.2, 2020, https://doi.org/10.13048/jkm.20015
  5. 한국에서 비만 치료에 쓰이는 한약에 대한 연구 동향 보고: 2015년부터 2019년까지의 국내외 논문을 중심으로 vol.30, pp.4, 2020, https://doi.org/10.18325/jkmr.2020.30.4.89
  6. LC-MS/MS를 이용한 돼지 근육조직 중 dl-methylephedrine hydrochloride의 잔류 분석법 개발 vol.60, pp.4, 2017, https://doi.org/10.14405/kjvr.2020.60.4.209
  7. 과체중 및 비만 환자의 체중감량을 위한 식사량 조절 및 복합 한약 단기 치료(5일 레스큐 프로그램)의 효과와 안전성: 진료기반 연구 vol.20, pp.2, 2017, https://doi.org/10.15429/jkomor.2020.20.2.122
  8. 당뇨 환자의 체중감량을 위한 가미태음조위탕의 임상적 활용: 후향적 차트 리뷰 vol.42, pp.1, 2017, https://doi.org/10.13048/jkm.21004
  9. A System-Level Mechanism of Anmyungambi Decoction for Obesity: A Network Pharmacological Approach vol.11, pp.12, 2021, https://doi.org/10.3390/biom11121881